MedPath

A study on the effect of intermittent fasting in reducing the blood sugar level and number of medicines in type 2 diabetic patients.

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/09/057784
Lead Sponsor
Jawaharlal Nehru Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either gender and between the age of 18-75 years

2.Confirm cases of Type 2 Diabetes mellitus with HbA1c > 8.0 taking = 2 anti-diabetic medication

3.Willing to perform intermittent fasting as per instructions.

4.Willing to give informed consent.

Exclusion Criteria

1.Pregnant or lactating females

2.Patients having history of any major cardiovascular or neurovascular event in past like CVA/Stroke

3.Patients with significant active liver or kidney diseases

4.Patients with history of any endocrinal diseases

5.Patients on chronic medication which are known to affect the glycemic status of the patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of intermittent fasting on glycemic control in patients with type II diabetes mellites on polypharmacy over a period of 12 weeksTimepoint: The overall duration of the study will be for 12 weeks, and the patient will be asked to come for follow up at the end of 4th, 8th, and 12th week.
Secondary Outcome Measures
NameTimeMethod
1.To assess the effect of intermittent fasting on glycemic control in pre-diabetic patients over a period of 12 weeks <br/ ><br>2.To determine the post intermittent fasting reduction in medication in patients of diabetes mellitus on polypharmacy prescription. <br/ ><br>3.To assess the effect of intermittent fasting on biochemical parameters in pre-diabetic patients over a period of 12 weeks <br/ ><br>4.To assess the adverse reaction in patients of diabetes mellitus undergoing intermittent fasting over a period of 12 weeks <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath